These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8692245)

  • 1. Olestra and the FDA.
    Karstadt M; Jacobson MF
    N Engl J Med; 1996 Aug; 335(9):669-70; author reply 670. PubMed ID: 8692245
    [No Abstract]   [Full Text] [Related]  

  • 2. Olestra and the FDA.
    Blackburn H
    N Engl J Med; 1996 Apr; 334(15):984-6. PubMed ID: 8596603
    [No Abstract]   [Full Text] [Related]  

  • 3. Sucrose polyester in human volunteers.
    Zorich N; Allgood G; Peters J
    Br J Nutr; 1999 Feb; 81(2):169-70; discussion 170-1. PubMed ID: 10450336
    [No Abstract]   [Full Text] [Related]  

  • 4. Olestra and the FDA.
    Stampfer MJ; Willett WC
    N Engl J Med; 1996 Aug; 335(9):669; author reply 670. PubMed ID: 8692244
    [No Abstract]   [Full Text] [Related]  

  • 5. Olestra and the FDA.
    Kleinman RE; Schneeman B
    N Engl J Med; 1996 Aug; 335(9):668; author reply 670. PubMed ID: 8692242
    [No Abstract]   [Full Text] [Related]  

  • 6. The selling of olestra.
    Nestle M
    Public Health Rep; 1998; 113(6):508-20. PubMed ID: 9847922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olestra at the movies.
    Harv Heart Lett; 1998 May; 8(9):7-8. PubMed ID: 9579116
    [No Abstract]   [Full Text] [Related]  

  • 8. Review and analysis of the effects of olestra, a dietary fat substitute, on gastrointestinal function and symptoms.
    Freston JW; Ahnen DJ; Czinn SJ; Earnest DL; Farthing MJ; Gorbach SL; Hunt RH; Sandler RS; Schuster MM
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):210-8. PubMed ID: 9356284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olestra snacks compared with regular snacks.
    Jacobson MF
    Ann Intern Med; 1999 Dec; 131(11):866. PubMed ID: 10610637
    [No Abstract]   [Full Text] [Related]  

  • 10. Fat, foreboding, and flatulence.
    Spiro HM
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):320-2. PubMed ID: 10068391
    [No Abstract]   [Full Text] [Related]  

  • 11. Postmarketing surveillance of new food ingredients: design and implementation of the program for the fat replacer olestra.
    Slough CL; Miday RK; Zorich NL; Jones JK
    Regul Toxicol Pharmacol; 2001 Apr; 33(2):218-23. PubMed ID: 11350204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olestra: a new food additive.
    Prince DM; Welschenbach MA
    J Am Diet Assoc; 1998 May; 98(5):565-9. PubMed ID: 9597030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal symptoms in 3181 volunteers ingesting snack foods containing olestra or triglycerides. A 6-week randomized, placebo-controlled trial.
    Sandler RS; Zorich NL; Filloon TG; Wiseman HB; Lietz DJ; Brock MH; Royer MG; Miday RK
    Ann Intern Med; 1999 Feb; 130(4 Pt 1):253-61. PubMed ID: 10068382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postmarketing surveillance of new food ingredients: results from the program with the fat replacer olestra.
    Allgood GS; Kuter DJ; Roll KT; Taylor SL; Zorich NL
    Regul Toxicol Pharmacol; 2001 Apr; 33(2):224-33. PubMed ID: 11350205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal symptoms following olestra consumption.
    Jacobson MF; Brown MA; Whorton EB
    JAMA; 1998 Jul 22-29; 280(4):325-7. PubMed ID: 9686546
    [No Abstract]   [Full Text] [Related]  

  • 16. Olestra and the FDA.
    Manning WJ
    N Engl J Med; 1996 Aug; 335(9):668-9; author reply 670. PubMed ID: 8692243
    [No Abstract]   [Full Text] [Related]  

  • 17. Fat substitute gets FDA approval.
    Rutter TL
    BMJ; 1996 Feb; 312(7026):270. PubMed ID: 8611777
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of olestra and sorbitol consumption on objective measures of diarrhea: impact of stool viscosity on common gastrointestinal symptoms.
    McRorie J; Zorich N; Riccardi K; Bishop L; Filloon T; Wason S; Giannella R
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):59-67. PubMed ID: 10715225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe gastrointestinal illness associated with olestra ingestion.
    Barlam TF; McCloud E
    J Pediatr Gastroenterol Nutr; 2003 Jul; 37(1):95-6. PubMed ID: 12827015
    [No Abstract]   [Full Text] [Related]  

  • 20. Additive gastrointestinal effects with concomitant use of olestra and orlistat.
    Heck AM; Calis KA; McDuffie JR; Carobene SE; Yanovski JA
    Ann Pharmacother; 2002 Jun; 36(6):1003-5. PubMed ID: 12022901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.